Justice Department targets $10 billion skin substitute fraud spree

Skin substitutes have become one of the most expensive pressure points in Medicare, with taxpayer costs exploding from about $250 million in 2019 to more than $10 billion in 2024 even as the number of patients treated only doubled. That mismatch has put wound-care billing under a federal microscope, as the Justice Department and Medicare regulators move to close a reimbursement pipeline that prosecutors say was exploited for huge false claims and luxury spending.

The Centers for Medicare & Medicaid Services said its calendar year 2026 Medicare Physician Fee Schedule final rule was designed to reduce waste and unnecessary use of skin substitutes and protect taxpayers. The agency’s response followed a September 2025 warning from the HHS Office of Inspector General that Medicare Part B payment trends for these products raised major concerns about fraud, waste and abuse. CMS also withdrew certain local coverage determinations for skin substitute grafts and cellular and tissue-based products that had been scheduled to take effect on January 1, 2026, signaling how quickly the policy response accelerated as spending ballooned.

The enforcement numbers show why. In the 2025 National Health Care Fraud Takedown, the Justice Department said prosecutors charged 324 defendants in 50 federal districts in connection with more than $14.6 billion in intended loss. Within that sweep, seven defendants were charged over about $1.1 billion in fraudulent Medicare claims for skin substitutes. In a separate speech, the department said five medical professionals were charged in a scheme involving about $1 billion in fraudulent claims for medically unnecessary skin grafts.

Justice Department officials have framed the skin-substitute cases as part of a broader pattern of kickbacks, unnecessary wound products and personal enrichment. In December 2025, prosecutors said owners of several Arizona wound graft companies were sentenced for causing more than $1.2 billion in false and fraudulent claims. In another 2025 case, the government said it seized more than $70 million, including four luxury vehicles, gold, jewelry and cash.

The crackdown reflects a wider escalation in health care fraud enforcement. Under Merrick B. Garland, the department’s 2024 enforcement action charged 193 defendants in 32 federal districts and involved about $2.75 billion in false claims. Under Pamela Bondi, the 2025 takedown nearly doubled the defendant count and pushed intended losses above $14.6 billion. For the Justice Department, skin substitutes have become a vivid example of what happens when a niche medical product meets loose billing incentives: a fast-growing line item, a fraud magnet and a direct hit to Medicare’s balance sheet.